ASBP

Conviction 80HealthcareScan · Thu, Jun 25, 2026

Bearish harami

ASBP$6.35-2.98%

ResistanceSupportVol 14

Vol MA14 1.07M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Aspire Biopharma Holdings, Inc.PHARMACEUTICAL PREPARATIONSwww.aspirebiolabs.com ↗

Price6.35

Change-2.98%

Gap-1.61%

Rel volume0.01×

Avg volume779.83K

Avg $ vol4.02M

SMA 205.98

SMA 503.81

SMA 2001.45

Price vs 50+66.47%

Price vs 200+337.03%

MA stackbullish

50/200 cross—

Supertrendup · 3.90

RSI (14)58

MACD hist-0.09

MACD cross—

Stoch %K / %D75 / 75

ADX (14)31

+DI / −DI22 / 17

RSI divergence—

MACD divergence—

ATR %+12.90%

ADR %14.21%

52w high6.68

52w low0.0519

From 52w high-5.01%

Above 52w low+12125.43%

New 52w highNo

SqueezeOn · 6d

Bollinger width28.95%

%B0.71

Donchian pos74.61%

Donchian high6.99

Donchian low4.45

AVWAP (52w high)5.59

vs AVWAP high+13.45%

AVWAP (52w low)0.4171

vs AVWAP low+1421.12%

OBV trendDown

Chaikin MF (20)-0.31

Today vs 20d0.01×

Avg vol (14d)1.07M

Avg vol (20d)779.83K

Avg $ vol (20d)4.02M

Market cap8.22M

RS 3m (vs SPY)+702.19%

RS 6m (vs SPY)+6593.08%

RS line new highNo

Trend template8/8

Technical rank96.4

1 week-0.24%

1 month+25.15%

3 months+461.50%

6 months+6441.24%

1 year+2230.15%

YTD+4534.77%

P/E-0.34

P/B2.12

P/S—

P/FCF—

EPS-16.38

Div yield—

ROE-632.83%

ROA-343.97%

Debt/Eq—

Current2.26

EV/EBITDA—

Gross margin-1.87%

Net margin—

Rev growth—

EPS growth-1768.95%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value2.36M

Revenue28.35K

Net income-3.22M

Gross profit5.75K

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out1.3M

Employees—

ListedThu, Feb 20, 2025

Free float4.51M

Float %89.7%

Short interest123.88K

Days to cover0.2d

Short volume22.3%

Squeeze score6 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank96.4 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBearish harami

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ASBP

All disclosures →

No recent disclosed trades by Congress in ASBP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ASBP

No recent insider (Form 4) filings in ASBP. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in ASBP · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.